Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

S-013420

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
OBJECTIVES New antimicrobials are essential to prevent gonorrhoea becoming an untreatable infection. Herein, the in vitro… Expand
  • table 1
  • figure 1
2014
2014
Ketolides are erythromycin A derivatives with a keto group replacing the cladinose sugar and an aryl-alkyl group attached to the… Expand
2014
2014
The pharmacodynamic profile of modithromycin (EDP-420, EP-013420, S-013420), a novel bicyclolide, was evaluated in a neutropenic… Expand
2010
2010
ABSTRACT The pharmacokinetic (PK)/pharmacodynamic (PD) parameters and the antibacterial activity of S-013420, a novel bicyclolide… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • table 3
2010
2010
OBJECTIVES The in vitro activity of S-013420, a novel bicyclolide, was investigated. METHODS All test strains for this study… Expand
  • figure 1
  • table 1
  • table 1
  • figure 2
  • table 2
2009
2009
ABSTRACT S-013420 (EDP-420) is a novel bicyclolide (bridged bicyclic macrolide) antibacterial currently under development for the… Expand
  • table 1
  • table 2
  • figure 1
  • table 3
  • figure 2
2009
2009
  • L. Jiang, Y. Or
  • Antimicrobial Agents and Chemotherapy
  • 2009
  • Corpus ID: 19597258
ABSTRACT EDP-420 (also known as EP-013420, or S-013420) is a first-in-class bridged bicyclolide currently in clinical development… Expand
  • figure 1
  • figure 2
  • table 1
  • table 2
  • figure 4
2009
2009
ABSTRACT EDP-420 (EP-013420, S-013420) is a first-in-class bicyclolide (bridged bicyclic macrolide) currently in clinical… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3